Author Information
Therese Sørlie is a renowned researcher affiliated with the Department of Cancer Genetics at Oslo University Hospital, Oslo, Norway. Her work primarily focuses on breast cancer research, encompassing a range of studies from molecular subtype prediction to understanding the mechanisms behind therapy resistance.Research Contributions
Therese Sørlie has made significant contributions to the field of breast cancer research. In 2021 alone, she has published multiple papers addressing various aspects of breast cancer, including spatial profiling, modifiable risk factors, multi-omics marker analysis for early prediction of tumor progression, RNA sequencing for clinical assessment, and the influence of sample preparation on recurrence scores. Her research in 2020 focused on mechanisms of endocrine therapy resistance, re-definition of breast cancer phenotypes, associations with HER2-positive breast cancers, and the distinct nature of basal-like DCIS lesions. Her work also includes identifying DNA copy number motifs as predictors of survival in breast cancer.Aliases
Therese Sørlie is also known by various aliases in academic publications, including T Sørlie, T. Sorlie, Therese Sørlie, T Sorlie, Thérèse Sørlie, and T. Sørlie.Publication and Citation Metrics
| Metric |
Value |
| Total Citations |
40,928 |
| H-Index |
44 |
| Total Papers |
147 |
